학술논문

Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways
Document Type
article
Source
Journal of Allergy and Clinical Immunology. 147(3)
Subject
Biomedical and Clinical Sciences
Immunology
Biotechnology
Genetics
Lung
Human Genome
Asthma
Aetiology
2.1 Biological and endogenous factors
Inflammatory and immune system
Respiratory
Adult
Chromosomes
Human
Pair 17
Disease Progression
Genetic Association Studies
Genotype
Humans
Middle Aged
Neoplasm Proteins
Polymorphism
Single Nucleotide
Quantitative Trait Loci
Respiratory Mucosa
Sequence Analysis
RNA
Severity of Illness Index
Whole Genome Sequencing
Antiviral pathways
asthma exacerbations
asthma severity
eQTL
genetics
GSDMA
GSDMB
PGAP3
whole-genome sequence
RNAseq
NHLBI Severe Asthma Research Program
Allergy
Language
Abstract
BackgroundThe Chr17q12-21.2 region is the strongest and most consistently associated region with asthma susceptibility. The functional genes or single nucleotide polymorphisms (SNPs) are not obvious due to linkage disequilibrium.ObjectivesWe sought to comprehensively investigate whole-genome sequence and RNA sequence from human bronchial epithelial cells to dissect functional genes/SNPs for asthma severity in the Severe Asthma Research Program.MethodsExpression quantitative trait loci analysis (n = 114), correlation analysis (n = 156) of gene expression and asthma phenotypes, and pathway analysis were performed in bronchial epithelial cells and replicated. Genetic association for asthma severity (426 severe vs 531 nonsevere asthma) and longitudinal asthma exacerbations (n = 273) was performed.ResultsMultiple SNPs in gasdermin B (GSDMB) associated with asthma severity (odds ratio, >1.25) and longitudinal asthma exacerbations (P < .05). Expression quantitative trait loci analyses identified multiple SNPs associated with expression levels of post-GPI attachment to proteins 3, GSDMB, or gasdermin A (3.1 × 10-9 -4). Higher expression levels of GSDMB correlated with asthma and greater number of exacerbations (P < .05). Expression levels of GSDMB correlated with genes involved in IFN signaling, MHC class I antigen presentation, and immune system pathways (false-discovery rate-adjusted P < .05). rs1031458 and rs3902920 in GSDMB colocalized with IFN regulatory factor binding sites and associated with GSDMB expression, asthma severity, and asthma exacerbations (P < .05).ConclusionsBy using a unique set of gene expression data from lung cells obtained using bronchoscopy from comprehensively characterized subjects with asthma, we show that SNPs in GSDMB associated with asthma severity, exacerbations, and GSDMB expression levels. Furthermore, its expression levels correlated with asthma exacerbations and antiviral pathways. Thus, GSDMB is a functional gene for both asthma susceptibility and severity.